Literature Search

Li(Zibo),Heng(Jianfu),Yan(Jinhua),Guo(Xinwu)… Breast Cancer Res Treat 0000-00-00

...SYK, TGFBR2, TNFRSF10D, WIF1, and WRN) annotated with potential TFBSs in the promoter regions showed negative correlatio...

Unsworth(A J),Kriek(N),Bye(A P),Naran(K),Sag… J Thromb Haemost 0000-00-00

...Syk, PLCγ2, FAK and Akt was also observed as a result of reduced interaction of the integrin β3 subunit with Gα13. Studi...

Peraldo Neia(Caterina),Cavalloni(Giuliana),C… Oncotarget 0000-00-00

...SYK and LGALS1; their silencing caused a significantly reduction of migration, but did not affect proliferation in in vi...

Erasmus(M Frank),Matlawska-Wasowska(Ksenia),… Sci Signal 0000-00-00

...Syk. For comparison, we evaluated pre-BCR aggregation mediated by dimeric galectin-1, which has binding sites for carboh...

Wang(Shao-Hung),Wang(Shou-Chieh),Chen(Pei-Ch… Med Mycol 0000-00-00

...Syk inhibitor Syk inhibitor, and epidermal growth factor receptor (EGFR) inhibitor PD168393 to identify which one was th...

Blunt(Matthew D),Koehrer(Stefan),Dobson(Rach… Clin Cancer Res 0000-00-00

...Syk/JAK inhibitor currently in clinical trials (NCT01994382), may improve treatment responses in patients.,PBMCs from CL...

Roskoski(Robert) Pharmacol Res 0000-00-00

...SYK protein kinases following activation of the B cell receptor. BTK in turn catalyzes the phosphorylation and activatio...

Shah(Spandan),Gibson(Andrew W),Ji(Chuanyi),D… J Leukoc Biol 0000-00-00

...Syk recruitment and activation. With in vitro kinase assays, PKC-δ and PKA show preferential phosphorylation of S51. Ser...

Pereira(Milton),Tourlomousis(Panagiotis),Wri… Nat Commun 0000-00-00

...SYK)-mediated NLRP3 activation and repressing inflammasome-associated caspase-8 activity. CARD9 is suppressed during Sal...

Kaur(Maninder),Silakari(Om) J Biomol Struct Dyn 0000-00-00

...Syk) and janus kinase 3 (JAK3), keys players in immune signaling, by developing ideal pharmacophores integrating Ligand-...